SG

Sankara Guha Dwarakanath Bellur

Active Director Director DIN 05228822
DIN 05228822 First appointment Nov 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2013
Shareholding value •••• Premium profile

About Sankara Guha Dwarakanath Bellur

Data last updated:

Sankara Guha Dwarakanath Bellur is a Director at Sceolex Pharma Private Limited (since 2013). The company operates in Pharma. Sceolex Pharma Private Limited reported revenue of ₹1.12 Cr (FY 2025).

DIN 05228822
Primary Designation Director
Industry Pharma
First Appointment 01 Nov 2013
Oldest Company Age 13 yrs
Largest company Sceolex Pharma Private Limited · ₹1.12 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sceolex Pharma Private Limited U24110KA2012PTC066676
Director01 Nov 20132012₹1.12 Cr (FY 2025)Active

Board colleagues of Sankara Guha Dwarakanath Bellur

Directorship timeline

Open interactive timeline →
Sceolex Pharma Private Limited
Premium access

Shareholding and investment profile for Sankara Guha Dwarakanath Bellur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sankara Guha Dwarakanath Bellur

Sankara Guha Dwarakanath Bellur currently holds 1 directorship: Sceolex Pharma Private Limited (Director, since 01 Nov 2013, revenue ₹1.12 Cr (FY 2025)).

Sankara Guha Dwarakanath Bellur was first appointed on 01 Nov 2013 as Director at Sceolex Pharma Private Limited.

The current boards of Sankara Guha Dwarakanath Bellur's companies include Bellur Mekhala Dwarakanath (Sceolex Pharma Private Limited), Surayanarayanarao Savithri (Sceolex Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available